BioCentury | Dec 7, 2016
Clinical News

Topical pritelivir: Ph II LipP1 started

...AiCuris began the double-blind, U.S. Phase II LipP1 trial to compare 5% topical pritelivir applied to labial...
...& Co. KG , Wuppertal, Germany Product: Topical pritelivir (topical AIC316) Business: Infectious Molecular target: NA Description: Topical pritelivir...
...and safety Status: Phase II started Milestone: Phase II data (2H17) Julian Zhu Topical pritelivir AiCuris GmbH & Co. KG Topical AIC316...
BioCentury | Sep 5, 2016
Clinical News

Topical pritelivir: Phase I data

...from the U.S. Phase I AIC316-02-I-01 trial in 46 healthy volunteers showed that once-daily 5% topical pritelivir...
...21 days met the primary endpoint by showing no cumulative irritation potential. Each subject received topical pritelivir...
...caused local irritation in all subjects. AiCuris GmbH & Co. KG , Wuppertal, Germany Product: Topical pritelivir...
Items per page:
1 - 2 of 2